Expression and implication of toll-like receptors TLR2, TLR4 and TLR9 in colonic mucosa of patients with ulcerative colitis

Abstract

Toll-like receptors (TLRs) family may play important roles in inflammatory bowel disease. This study examined the expression of TLR2, TLR4 and TLR9 in the colonic tissues of patients with ulcerative colitis (UC) and explored their roles in the pathogenesis of UC. Colonic biopsies were taken from the colon of 30 patients with mild or moderate UC (at active phase) and 10 healthy controls during colonoscopy. TLR2, TLR4 and TLR9 protein expression levels were immunohistochemically detected. The mRNA expression levels of TLR2, TLR4 and TLR9 were assessed by reverse transcription polymerase chain reaction (RT-PCR). The disease activity index (DAI), colonoscopic and histologic grades and fecal microbial flora were determined. Histological examination showed that the intestinal mucous membrane of UC patients underwent acute inflammation changes. Immunohistochemistry exhibited that the expression levels of TLR2, TLR4 and TLR9 in colon epithelia and inflammatory cells were higher in UC patients than in control group (P<0.01). The mRNA expression levels of TLR2, TLR4 and TLR9 were increased in UC patients but were not detected in the normal controls. Expression levels of TLR2, TLR4 and TLR9 were positively correlated, and bore close correlation with DAI, colonoscopic and histologic grades and fecal microbial flora. An important mechanism of UC might be that abnormal activation of mucosal immunity by intestinal dysbacteriosis caused dysregulation of TLRS that mediates innate immunity.

Keywords

Toll-like receptors / ulcerative colitis / innate immunity

References

[1] PodolskyDK. Inflammatory bowel disease. N Engl J Med, 2002, 347(6): 417-429 PMID: 12167685

[2] ChowDK, LeongRW, TsoiKK, et al. . Long-term follow-up of ulcerative colitis in the Chinese population. Am J Gastroenterol, 2009, 104(3): 647-654 PMID: 19262521

[3] XavierRJ, PodolskyDK. Unravelling the pathogenesis of inflammatory bowel disease. Nature, 2007, 448(7152): 427-434 PMID: 17653185

[4] DrexlerSK, FoxwellBM. The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol, 2010, 42(4): 506-518 PMID: 19837184

[5] AbreuMT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol, 2010, 10(2): 131-144 PMID: 20098461

[6] AkiraS, TakedaK. Toll-like receptor signaling. Nat Rev Immunol, 2004, 4(7): 499-511 PMID: 15229469

[7] The Chinese medical association digestion of neurology, inflammatory bowel disease group.. To standardize the diagnosis and treatment of inflammatory bowel disease in China consensus opinion (JiNan). Chin J Dig (Chinese), 2007, 27(8): 545-550

[8] KornbluthA, SacharDB. Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol, 2004, 99(7): 1371-1385 PMID: 15233681

[9] TanY, ZouKF, YangT, et al. . Clinical effect of microecologic pharmaceutical in ulcerative colitis. Chin J Dig Endosc (Chinese), 2008, 25(2): 77-81

[10] ZhongYQ, ZhuZH, ChenWX, et al. . Endoscopic characteristics of active ulcerative colitis and its relationship with clinical features. Chin J Endoscopy (Chinese), 2000, 6(4): 7-8

[11] PullanRD, RhodesJ, GaneshS, et al. . Transdermal nicotine for active ulcerative colitis. N Engl J Med, 1994, 330(12): 811-815 PMID: 8114833

[12] MoynaghPN. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol, 2005, 26(9): 469-476 PMID: 16006187

[13] AkiraS, TakedaK, KaishoT. Toll-like receptors: critical proreins linking innate and acquired immunity. Nat Immunol, 2001, 2(8): 675-68 PMID: 11477402

[14] YoshimuraA, LienE, IngallsRR, et al. . Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immuno, 1999, 163(1): 1-5

[15] UlevitchRJ. Toll gates for pathogen selection. Nature, 1999, 40l(6755): 755-756

[16] KriegAM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Imnlunol, 2002, 20: 709-760

[17] MaYQ, LiGF. 102 CpG—the immunology function of DNA and its application. Foreign Med Sci (Chinese), 2003, 26(06): 318-321

[18] XunN, OuyangQ, YuZH, et al. . Toll-like receptor 4, CD14 and nuclear factor-κB in the expression and clinical significance of ulcerative colitis. Chin J Dig (Chinese), 2005, 25(7): 433-434

[19] GanHT, OuyangQ, JiaDQ, et al. . Activation of nuclear factor-?B and its relationship with cytokine gene expression in colonic mucosa of ulcerative colitis patients. Chin J Inter Med (Chinese), 2002, 41(4): 252-255

[20] SanorRB. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol, 2006, 3(7): 390-407

[21] CarioE, PodolskyDK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun, 2000, 68(12): 7010-7017 PMID: 11083826 PMCID: 97811

[22] ChenX, OuyangQ, ZhangWY. Expressions of TLR4 and HBD2 in colonic intestinal epithelium of ulcerative colitis. Chin J Gastroenterol Hepatol (Chinese), 2010, 19(5): 385-389

[23] LenoirC, SapinC, BroquetAH, et al. . MD-2 controls bacterial lipopolysaccharide hyporesponsiveness in human intestinal epitllelial cells. Life Sci, 2008, 82(9–10): 519-528 PMID: 18215718

[24] AbreuMT, VoraP, FaureE, et al. . Decreased expression of Toll-like receptor-4 and MD-2 Correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol, 2001, 167(3): 1609-1616 PMID: 11466383

[25] BockerU, YezerkyO, FeickP, et al. . Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with toll-like receptor 4 but not toll-like receptor 2 or CDl4 expression. Int J Colorectal Dis, 2003, 18(1): 25-32 PMID: 12458377

[26] Sánchez-MuñozF, Fonseca-CamarilloG, Villeda-RamírezMA, et al. . Transcript levels of Toll-like receptors 5, 8 and 9 correlate with inflammatory activity in ulcerative colitis. BMC Gastroenterol, 2011, 11: 138 PMID: 22185629 PMCID: 3287145

[27] HallJA, BouladouxN, SunCM, et al. . Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity, 2008, 29(4): 637-649 PMID: 18835196 PMCID: 2712925

[28] EwaschukJB, BackerJL, ChurchillTA, et al. . Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect Immun, 2007, 75(5): 2572-2579 PMID: 17325049 PMCID: 1865769

[29] FuseK, KatakuraK, SakamotoN, et al. . Toll-like receptor 9 gene mutations and polymorphisms in Japanese ulcerative colitis patients. World J Gastroenterol, 2010, 16(46): 5815-5821 PMID: 21155002 PMCID: 3001972

[30] LangeNE, ZhouX, Lasky-SuJ, et al. . Comprehensive genetic assessment of a functional TLR9 promoter polymorphism: no replicable association with asthma or asthma-related phenotypes. BMC Med Genet, 2011, 12: 26 PMID: 21324137 PMCID: 3048492

[31] ChenS, ZouKF, YangT, et al. . Expression and signficance of Toll-like receptor (TLR)2, TLR4 and TLR9 in colonic mucosa of rat model with induced colitis. Chin J Gastroenterol (Chinese), 2007, 12(6): 339-343